Press Release: Director's Dealings announcement according to --15a WpHG (the German Securities Trading Act)

Biofrontera AG / Director's Dealings announcement according to --15a WpHG (the German Securities Trading Act) . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Details of the person subject to the disclosure requirement Name: Baumann, Jürgen Person with executive functions: Member of administrative Professional role: or supervisory body

Designation of the financial instrument ISIN: DE0006046113 Designation: Shares of Biofrontera AG

Details of the transaction Type of transaction: Purchase Date: 27.05.2015 Place (stock exchange): off-exchange Price: 2.30 Currency: EUR Quantity: 1,819 Business volume: 4,183.70

Details of the company with the publishing obligation: Issuer: Biofrontera AG Hemmelrather Weg 201 51377 Leverkusen Germany

ISIN: DE0006046113 WKN: 604611

This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Biofrontera AG via Globenewswire

HUG#1924528

--- End of Message ---

Biofrontera AG

Hemmelrather Weg 201 Leverkusen Germany

WKN: 604611;ISIN: DE0006046113;

Listed: Freiverkehr in Börse Stuttgart,

Freiverkehr in Börse Berlin,

Freiverkehr in Bayerische Börse München,

Regulierter Markt in Frankfurter Wertpapierbörse,

Regulierter Markt in Börse Düsseldorf;

http://www.biofrontera.com/ (END) Dow Jones Newswires

   May 28, 2015 08:00 ET (12:00 GMT)- - 08 00 AM EDT 05-28-15